Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program,Expert Review of Pharmacoeconomics & Outcomes Research

当前位置： X-MOL 学术 › Expert Rev. Pharmacoecon. Outcomes Res. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 2.3 ) Pub Date : 2024-01-25 , DOI: 10.1080/14737167.2023.2283584
Michael J DiStefano ₁ , Antal Zemplenyi _{1,

2} , Kelly E Anderson ₁ , Nicholas D Mendola ₁ , Kavita V Nair ₃ , Robert Brett McQueen ₁

Affiliation

The United States has begun assessing the value of pharmaceuticals to inform negotiated prices in the Medicare program. Given strong political objections in the United States to the use of QALYs, M...

中文翻译：